Antipodes Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.6M | Sell |
|
|||||
|
2025
Q2 | $40M | Sell |
|
|||||
|
2025
Q1 | $43.1M | Buy |
|
|||||
|
2024
Q4 | $31.5M | Sell |
|
|||||
|
2024
Q3 | $38.3M | Sell |
|
|||||
|
2024
Q2 | $58M | Buy |
|
|||||
|
2024
Q1 | $30.7M | Buy |
|
|||||
|
2023
Q4 | $36.2M | Buy |
|
|||||
|
2023
Q3 | $19.5M | Buy |
|
|||||
|
2023
Q2 | $10K | Sell |
|
|||||
|
2023
Q1 | $28K | Buy |
|
|||||
|
2022
Q4 | $28K | Buy |
|